EVENTS
The information contained in each news post on this page was factually accurate on the date it was issued and posted.
EnWave Signs Commercial License with Sutro Biopharma for powderREV® Technology
Press release published by EnWave Corporation regarding the recent agreement with Sutro Biopharma, Inc. Read more
Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter
Scientific American Guest Blog Antibody-Drug Conjugates and Cancer Treatment: Making "Smart Bombs" Smarter By: Trevor J. Hallam Read More
Sutro Biopharma’s Trevor Hallam Offers a Glimpse into the Future of Drug Design
12/5/2011 - BioPharm International Podcast (3of3): Sutro Biopharma's Trevor Hallam offers a glimpse into the future of drug design By: Trevor J. Hallam
Sutro Biopharma’s Trevor Hallam Describes a Future cGMP Manufacturing Facility
BioPharm International Podcast (2of3): Sutro Biopharma's Trevor Hallam describes a future cGMP manufacturing facility By: Trevor J. Hallam
Sutro Biopharma and Cell-Free Protein Expression Systems
BioPharm International Podcast (1of3): Sutro Biopharma and Cell-Free Protein Expression Systems By: Trevor J. Hallam
Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production: A New Approach for Shortening Protein Production Development Timelines
PHARMACEUTICAL TECHNOLOGY Volume 35, pp. s8-s11 Industrializing Design, Development, and Manufacturing of Therapeutic Proteins By: Trevor J. Hallam, Christopher J. Murray.
“Unnatural Selection”
BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, "Unnatural Selection" in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan Schaeffer. Read More
Sutro Biopharma and Promising Protein Synthesis Technology
National Science Foundation (NSF) newsletter featuring Sutro Biopharma and Promising Protein Synthesis Technology. Read More